By Drs. Yuriy Abramov and Shanming Kuang, Center for Pharma Crystallization, J-Star Research Small molecule drug candidates tend to have different solid forms, including anhydrate, hydrate, solvate, salt, cocrystal...
Dr. Shanming Kuang is currently the Head of Center for Pharma Crystallization at Porton Shanghai and Senior Director of Solid Form Studies at J-Stat Research. Shanming obtained his PhD...
Dr. Yuriy Abramov is an industrial computational scientist with over 18 years experience at Pfizer Inc. Currently he holds a position of an Executive Director of computational chemistry and...
Dr. Nima Yazdanpanah is a consultant on advanced manufacturing and modeling and simulation applications in Bio/pharmaceutical and fine chemical industries. His area of expertise covers process simulation, particulate matters,...
By Dr. Nima Yazdanpanah, Consultant, Procegence Mechanistic modelling and process simulation, based on first-principle analysis, is a well-practiced tool in the chemical industry. The diverse applications have been enabled...
Currently Chief Technology Officer at Porton Pharmatech/J-Star Research, Inc. San Kiang is an SME in continuous processing API, continuous processing DP, particle engineering, pharmaceutical composite material, co-processing and pharmaceutical...
By Dr. San Kiang, J-Star Research / Porton The business goal of most CMC development is to reach FIH as fast as possible. However, before IND or Phase 1,...
By Dr. Simon Bates, Rigaku Americas Corp X-ray powder diffraction has been the gold standard for solid state pharmaceutical analysis for quite some time. However, when it comes to...
Dr. Simon Bates is currently V.P. of Science and Technology at Rigaku Americas Corp., where he nurtures collaborative relationships between industry partners and academia in the discovery of new...
Dr. Robert Docherty did his degree and PhD. at Strathclyde University and joined ICI/Zeneca in 1988 where he worked on the solid-state structure and crystallization of dyes, pigments, biocides,...
